Lidocaine topical - Phosphagenics

Drug Profile

Lidocaine topical - Phosphagenics

Alternative Names: TPM® lidocaine; TPM®/lidocaine; TPM®/Lidocaine transdermal matrix patch

Latest Information Update: 25 Oct 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Phosphagenics
  • Class Acetanilides; Class Ib antiarrhythmics; Local anaesthetics; Small molecules
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase I/II Pain

Most Recent Events

  • 16 Feb 2016 Phase-I/II clinical trials in Pain in Australia (Topical)
  • 24 Sep 2013 Biomarkers information updated
  • 01 Aug 2013 Clinical development is ongoing
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top